top of page

Developed by researchers and doctors



Endometrial cancer

Tumor biomarkers

Diagnostic tools




Risk analysis

Risk analysis

Quality of care

Quality of life

ENDORISK can help patients and health care professionals in personalized treatment of endometrial carcinoma using: tumor biomarkers, blood, imaging, risk analysis, quality of life.

ENDORISk is a personalized model which can predict the risk of lymph node metastases and survival in patients with endometrial carcinoma. Several diagnostic variables can be used in the model, such as pathology, imaging and tumor markers.


ENDORISK is a Bayesian network. This is a probabilistic model, which means that the model calculates the chance of an outcome for each separate variable. The outcomes in ENDORISK are lymph node metastases and survival.

The model also calculates correlations between variables. This enables the possibility to model and analyse dependent and independent relations between variables. Variables that do not have a high individual predictive quality can have a higher collective predictive quality together with other variables. Another advantage of a Bayesian network is that it is not necessary to input all variables to calculate an outcome.

bottom of page